Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Expert Q&A: Navigating Complexity In Modern Small Molecule Development
Small molecules are growing larger, more potent, and more structurally complex while timelines compress. That combination reshapes scale-up, outsourcing relationships, and the criteria for choosing a manufacturing partner.
-
A Connected Approach To OSD Development
See how an integrated OSD development strategy can identify risks early, strengthen process understanding and prepare products for scale-up, tech transfer and commercialization.
-
Is Your API Right For A Soft Gel Capsule?
Soft gel delivery systems can enhance bioavailability, enable controlled release, support combination dosing, and handle potent compounds while improving stability and patient adherence.
-
How A CDMO Overcomes Soft Gel Formulation Challenges
Softgel development demands careful control of shell properties, liquid fills, and stability. Overcoming formulation challenges improves drug delivery, bioavailability, and shelf life.
-
Oral Solutions & Suspensions: The Art Of Pharmacy
Oral liquid formulations improve accessibility and dosing flexibility. Learn how developers overcome stability, taste-masking, and manufacturing challenges.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Turning A "Brick Dust" Compound Into A Clinically Viable Oral Formulation
Advanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.
-
Creating A New Dosage Form From An Approved Drug For A New Rare Disease
Advancing approved drugs into new indications requires smart formulation, strong quality controls, and regulatory expertise to overcome challenges and accelerate patient access.
-
Improved Oligonucleotide LC–MS Performance
Metal surfaces and PFAS-based ion-pair reagents limit oligonucleotide LC-MS. Inert hardware and ion-pair-free separation modes change recovery, resolution, and spectral clarity in ways worth examining.
-
Integrated LC/UV And LC/MS Workflows For Impurity And Degradation
Fatty acid-modified GLP-1 peptides carry hydrophobicity and impurity profiles that strain separation. Pairing LC/UV with mass spectrometry exposes degradation and supplier-to-supplier differences.
-
LC/MS Characterization Of GLP-1 Receptor Agonist Oligomers
Liraglutide isomers diverge in oligomerization, while unexpected impurities resist routine identification. Pairing fast screening with targeted sequence analysis supports confident impurity assignment.
FORMULATION DEVELOPMENT SOLUTIONS
- Save Time And Money Quantifying Gene Expression
- Multiparticulates For Modified Release Systems
- Single-Use Automated Virus Filtration System
- Drug Product Development And Manufacturing Services
- Small is Powerful
- Neotame And Sucralose: Two Ways To Ace The Taste Test
- High-Content Screening System
- Drug-Drug Interaction (DDI) Studies
- Streamline Experiments From Design To Decide
- Rescuing Proteins With Scalable Insect Expression
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence
- Bracco To Build New Injectable Drug Manufacturing Facility In North Carolina
- Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand
- ROSS Portable High Shear Mixing System
- Ardena Launches Online Biomarker Catalogue: 228 Markers, One Quote Request
- Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus
- Global Pharma Manufacturing Community Meets In Berlin For PHARMAP 2027
- LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical And GLP Bioanalytical Services
- MVIC And Upperton Pharma Solutions Announce Strategic Collaboration
- All-In-One Solution For Continuous Microbial Monitoring Without Production Interruptions